Maryam Zarghami Dehaghani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maryam Zarghami Dehaghani has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Amin Hamed Mashhadzadeh
Department of Mechanical Engineering, Nazarbayev University, Kazakhstan
2 shared publications Amin Hamed Mashhadzadeh
Nazarbayev Univ, Sch Engn & Digital Sci, Dept Chem & Mat Engn, 53 Kabanbay Batyr Ave, Astana 010000, Kazakhstan
1 shared publication- Anand Prakash Dwivedi
Mechanical Engineering and Robotics, Guangdong Technion Israel Institute of Technology, Shantou, China
1 shared publication Boris Golman
Nazarbayev Univ, Sch Engn & Digital Sci, Dept Chem & Mat Engn, 53 Kabanbay Batyr Ave, Astana 010000, Kazakhstan
1 shared publication- Boris Golman
Department of Chemical and Materials Engineering, School of Engineering and Digital Sciences, Nazarbayev University, Astana, Kazakhstan
1 shared publication - Charalabos Constantinos Doumanidis
American University of Phnom Penh, Russey Keo, Phnom Penh, Cambodia
1 shared publication
Latest Publications
- Open Access
- 16 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (26) , 20682-20694
Predictive stochastic modeling of mechanically alloyed particle size and shape
Ball milling bimetallic materials creates tailored particles—size, shape, and nanostructure define performance for catalysis, energy, and beyond.
- 16 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (26) , 20682-20694
Open AccessPredictive stochastic modeling of mechanically alloyed particle size and shape
Ball milling bimetallic materials creates tailored particles—size, shape, and nanostructure define performance for catalysis, energy, and beyond.
- Open Access
Theoretical Encapsulation of Fluorouracil (5-FU) Anti-Cancer Chemotherapy Drug into Carbon Nanotubes (CNT) and Boron Nitride Nanotubes (BNNT)
Introduction: Chemotherapy with anti-cancer drugs is considered the most common approach for killing cancer cells in the human body. However, some barriers such as toxicity and side effects would limit its usage. In this regard, nano-based drug delivery systems have emerged as cost-effective and efficient for sustained and targeted drug delivery. Nanotubes such as carbon nanotubes (CNT) and boron nitride nanotubes (BNNT) are promising nanocarriers that provide the cargo with a large inner volume for encapsulation. However, understanding the insertion process of the anti-cancer drugs into the nanotubes and demonstrating drug-nanotube interactions starts with theoretical analysis. Methods: First, interactions parameters of the atoms of 5-FU were quantified from the DREIDING force field. Second, the storage capacity of BNNT (8,8) was simulated to count the number of drugs 5-FU encapsulated inside the cavity of the nanotubes. In terms of the encapsulation process of the one drug 5-FU into nanotubes, it was clarified that the drug 5-FU was more rapidly adsorbed into the cavity of the BNNT compared with the CNT due to the higher van der Waals (vdW) interaction energy between the drug and the BNNT. Results: The obtained values of free energy confirmed that the encapsulation process of the drug inside the CNT and BNNT occurred spontaneously with the free energies of −14 and −25 kcal·mol−1, respectively. Discussion: However, the lower value of the free energy in the system containing the BNNT unraveled more stability of the encapsulated drug inside the cavity of the BNNT comparing the system having CNT. The encapsulation of Fluorouracil (5-FU) anti-cancer chemotherapy drug (commercial name: Adrucil®) into CNT (8,8) and BNNT (8,8) with the length of 20 Å in an aqueous solution was discussed herein applying molecular dynamics (MD) simulation.
Open AccessTheoretical Encapsulation of Fluorouracil (5-FU) Anti-Cancer Chemotherapy Drug into Carbon Nanotubes (CNT) and Boron Nitride Nanotubes (BNNT)
Introduction: Chemotherapy with anti-cancer drugs is considered the most common approach for killing cancer cells in the human body. However, some barriers such as toxicity and side effects would limit its usage. In this regard, nano-based drug delivery systems have emerged as cost-effective and efficient for sustained and targeted drug delivery. Nanotubes such as carbon nanotubes (CNT) and boron nitride nanotubes (BNNT) are promising nanocarriers that provide the cargo with a large inner volume for encapsulation. However, understanding the insertion process of the anti-cancer drugs into the nanotubes and demonstrating drug-nanotube interactions starts with theoretical analysis. Methods: First, interactions parameters of the atoms of 5-FU were quantified from the DREIDING force field. Second, the storage capacity of BNNT (8,8) was simulated to count the number of drugs 5-FU encapsulated inside the cavity of the nanotubes. In terms of the encapsulation process of the one drug 5-FU into nanotubes, it was clarified that the drug 5-FU was more rapidly adsorbed into the cavity of the BNNT compared with the CNT due to the higher van der Waals (vdW) interaction energy between the drug and the BNNT. Results: The obtained values of free energy confirmed that the encapsulation process of the drug inside the CNT and BNNT occurred spontaneously with the free energies of −14 and −25 kcal·mol−1, respectively. Discussion: However, the lower value of the free energy in the system containing the BNNT unraveled more stability of the encapsulated drug inside the cavity of the BNNT comparing the system having CNT. The encapsulation of Fluorouracil (5-FU) anti-cancer chemotherapy drug (commercial name: Adrucil®) into CNT (8,8) and BNNT (8,8) with the length of 20 Å in an aqueous solution was discussed herein applying molecular dynamics (MD) simulation.